Research Archive




	What's New II - Research Archive Archive of research links Please note - because these links are several months old, not all links may still be valid! ~ October 2007 ~ Simple Eye Scan Opens Window To Multiple Sclerosis Researchers Discover Gene Tied To Multiple Sclerosis Peptimmune Initiates Phase I Study With A Novel Peptide Copolymer For The Treatment Of Multiple Sclerosis Guide To Multiple Sclerosis Launches On New European Health Website Early Research Into A Treatment For Progressive MS, Scotland Genzyme And Bayer Schering Pharma AG, Germany Announce Start Of Phase 3 Program With Alemtuzumab For Treatment Of Multiple Sclerosis Multiple Sclerosis Patients Find Dietary Treatment More Effective Than Pharmaceutical Regimens Nerve Damage May Be Triggered By Cell-Surface Sugar Defects In Multiple Sclerosis Patients Sexual Dysfunction In Women With Newly Diagnosed Multiple Sclerosis Daily Express Claims Surrounding Fish Oil And MS Scotland Advises Tysabri Use In Highly Active Relapsing Remitting Multiple Sclerosis Smoking has no effect on progression of multiple sclerosis ~ September 2007 ~ Fast And Simple Screening Test For Early Diagnosis Of Common Brain Diseases Daily Express Claims Surrounding Fish Oil And MS Estrogen That Protects The Brain Without Increasing Cancer Risk May Treat MS Thalamic atrophy and cognition in multiple sclerosis Cell-surface Sugar Defects May Trigger Nerve Damage In Multiple Sclerosis Patients Review of Facing the Cognitive Challenges of Multiple Sclerosis Montel Williams to join MS walk in Yorktown Does the RT3 accelerometer spell the end of pen-and-paper questionnaires? Disease Activity Increases After MS Patients Stop Drug Inspirational New Guide Counsels Couples Coping With The Stress Of Chronic Illness Tysabri® Demonstrates Significant Health-Related Quality Of Life Improvements For Multiple Sclerosis Patients ~ August 2007 ~ Promising DNA Vaccine For Multiple Sclerosis New vaccine may help MS patients, study finds Risk Genes For Multiple Sclerosis Revealed By Research Teams Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study Early interferon therapy may delay MS disability A 4,300-mile trip east on two wheels Tysabri® Celebrates One-Year Anniversary As A Treatment For Multiple Sclerosis Childhood Sun Exposure May Influence Risk Of Developing Multiple Sclerosis MS Society Announces 2.4 Million Dollars To Continue Ottawa Bone Marrow Stem Cell Transplant Trial Immune System Variations May Underlie Differences In MS Between African Americans And Caucasians Men And Women Equally Transmit Genetic Risk Of MS To Their Children Potential For Earlier Detection Of Multiple Sclerosis Using New Imaging Crucial Role In Multiple Sclerosis Discovered Childhood-Onset MS Moves Slowly, But Disables Younger AAN: Rituximab Reduces MS Lesions and Relapses ~ July 2007 ~ Stem Cell Bill Passes MS, Activists Attend Event At U.S. Capitol - Stem Cell Bill Moves To President's Desk New imaging technique could promote early detection of MS European Union CHMP Recommends Approval of New Formulation of Multiple Sclerosis Treatment Rebif Both Parents May Pass MS Risk to Kids New Line Of Communication Between Nervous System Cells Discovered Unproven Goat Serum Treatment Under The Microscope ~ June 2007 ~ Positive Phase I/II Extension Trial with Tovaxin(TM) for MS - 92% reduction in annualized relapse rate Eye Protein Could Shield Against MS Phase 3 Trial Initiated for Laquinimod in Multiple Sclerosis Second Phase 3 Clinical Trial of Fampridine in Multiple Sclerosis Initiated MS targets women over men, 4 to 1 Super-Early MS Treatment Best Annual Meeting Of The Consortium Of Multiple Sclerosis Centers Orchestra Therapeutics Announces New Phase II Clinical Data On NeuroVax(TM) Unique MS Patient Database Now Widely Available Glucosamine-Like Supplement Inhibits Multiple Sclerosis, Type 1 Diabetes Data Presented At The American Academy Of Neurology's Annual Meeting Provide Update On Utilization And Safety Of Tysabri® For Multiple Sclerosis ~ May 2007 ~ AAN: Gender Gap Widens for Multiple Sclerosis TopAbstracts in Multiple Sclerosis 05/17/2007 Testosterone May Help Men With Multiple Sclerosis Genetics Consortium Finds Gene that May Protect Against MS Progress on Experimental Therapies for MS, and Much More, Reported at the American Academy of Neurology Meeting Ultra-High-Field MRI Allows For Earlier Diagnosis Of Multiple Sclerosis Possible Connection Between Women & MS Five new oral MS modifying drugs coming soon Mitoxantrone Can Extend Time to Disease Progression in Worsening Multiple Sclerosis: Presented at AAN TopAbstracts in Multiple Sclerosis 05/03/2007 Studies Suggest Investigational Agent Reduces Disease Activity in MS Early Interferon Beta-1b Use in Multiple Sclerosis Patients Slows Disability Onset: Presented at AAN Researchers Find Cells that May Promote Myelin Repair in MS Senate Passes Stem Cell Bill Despite Veto Threat AAN: Rituximab Reduces MS Lesions and Relapses Natalizumab (Tysabri) Reduces Vision Loss in MS Most MS Patients Miss Out on Key Drugs Laquinimod, A Novel Oral Compound, Showed Significant Reduction In Disease Activity In Patients With Relapsing - Remitting Multiple Sclerosis (RRMS) ~ April 2007 ~ MRI May Predict Multiple Sclerosis' Effect on Brain Brain stimulation may curb MS spasticity Familial Factors May Not Impact MS Severity: Study Researchers Stop MS-like Disease in Mice by Targeting a Blood Protein Genetically engineered human neural stem cells for brain repair in neurological diseases The effect of interferon-beta(1a) on relapses and progression of disability in patients with clinically isolated syndromes (CIS) suggestive of multiple sclerosis With Multiple Sclerosis, 'Permanent Arrest' May be Temporary MRI measure may predict progression of PPMS Was this information helpful? Then please consider making a donation. We are a small, independent nonprofit agency and are dependent on donations from our supporters. Thank you from all the staff at the MSA.
Home Disclaimer Privacy Policy Site Map Articles The Multiple Sclerosis Association of King County 753 North 35th St., Suite 208, Seattle, WA 98103 Phone: 206-633-2606 Fax: 206-633-2920 Email: info@msakc.org

What's New II - Research Archive